TomoTherapy co-founder Reckwerdt retires

TriMed Staff | | Health Imaging | Artificial Intelligence
TomoTherapy has announced that co-founder Paul J. Reckwerdt will retire as president and relinquish his board directorship, effective Dec. 31.

Reckwerdt plans to pursue entrepreneurial opportunities and will serve as a strategic advisor to Compact Particle Acceleration Corporation, which is developing a compact proton therapy system in partnership with TomoTherapy.

Reckwerdt co-founded TomoTherapy with Rock Mackie, PhD, to commercialize a precise form of radiation therapy that the two researched at University of Wisconsin in Madison.

TriMed Staff

Related Content

Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Routine abdominal CTs offer insight into cardiovascular risk
Up to half of medical organizations either already using or preparing to implement AI

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.